After a year of stripping back its head count and pipeline, Carisma Therapeutics is now cutting down to the bone and laying ...
Relmada Therapeutics’ attempts to see whether a magic mushroom extract could be used to treat obesity and metabolic diseases ...
Healthcare Asia Magazine on MSN4 天
Global cell and gene therapy market to reach $76b in 2030It will be driven by significant advancements in gastrointestinal disorders treatments. The global cell and gene therapy (CGT ...
2 小时
Khaleej Times on MSNLongevity clinics worth the hype? Dubai survey finds 90% worldwide rely on marketing over ...Nearly 90 per cent of longevity clinics worldwide provide treatments influenced more by marketing than by scientific evidence ...
For patients with atrial fibrillation and obesity, lifestyle modification plus antiarrhythmic drug therapy conferred various ...
Patients who have acute myocardial infarction (AMI) complicated by cardiogenic shock (CS) experience elevated mortality rates ...
Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, ...
China NMPA grants breakthrough therapy designation for Innovent’s PD-1/IL-2a-bias bispecific antibody fusion protein, IBI363 in melanoma: San Francisco, US Tuesday, April 1, 202 ...
7 小时
WCBD News 2 on MSNMedical manufacturer opens North Charleston facility, bringing job opportunitiesA medical manufacturing company has opened a new facility in North Charleston to build autoinjectors. Swiss-based SHL Medical ...
5 天
Live Science on MSN'Fish odor syndrome': A rare metabolic condition that makes sweat smell like rotten fishPatients with trimethylaminuria, or "fish odor syndrome," make too much of a chemical with a strong fishy smell.
PR Newswire SAN FRANCISCO and SUZHOU, China, March 30, 2025 SAN FRANCISCO and SUZHOU, China, March 30, 2025 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果